Project Grant HT94252410833
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$144K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
This $1,175,982 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a telehealth intervention aimed at improving quality of life and pancreatic cancer survivorship. The grant, awarded to the Beckman Research Institute of the City of Hope, a nonprofit research organization, will fund the development and implementation of this telehealth program over a 3-year period from August 2024 to July 2027. The project will leverage...
The federal Project Grant award of $1,319,487 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Beckman Research Institute of the City of Hope to target diabetes-associated radioresistance in order to improve prostate cancer control and quality-of-life outcomes. The award, which runs from September 15, 2025 to September 14, 2029, will fund sophisticated medical research initiatives at the Beckman Research Institute...
The Defense Health Agency (DHA) awarded a $999,997 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Beckman Research Institute of the City of Hope for the "PERIOPERATIVE OSTOMY SELF-MANAGEMENT TELEHEALTH INTERVENTION FOR CANCER SURVIVORS" project. The grant, awarded on September 15, 2024, will fund research to develop a telehealth intervention to support self-management for cancer survivors with ostomies. As a nonprofit medical research...
The Defense Health Agency awarded a $5,339,958 Project Grant to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a digital health intervention for self-management and telemonitoring in chimeric antigen receptor (CAR)-T cell therapy. This 4-year research project, running from June 2025 to June 2029, aims to advance medical solutions for the battlefield and transform healthcare for...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $388,194 to The Johns Hopkins University to conduct research on "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for critical health challenges. The 3-year project, running from...
This Project Grant award for $845,928.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research conducted by The Trustees of Columbia University in the City of New York, Health Sciences Division, to enhance early detection of pancreatic cancer using GPT-embedded electronic health record (EHR) models. The goal is to develop a novel approach that improves predictive performance and interpretability for earlier identification...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $301,000.00 to the University of Miami to develop an eHealth psychosocial stress and symptom management intervention for patients with pancreatic cancer. The project aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis, treatment, and management....
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $571,350.00 in funding to the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, California. The award supports research aimed at developing metabolic interventions to halt the progression of pancreatic cancer. SBP, an independent non-profit biomedical research organization, will leverage advanced technologies and...
This Project Grant award in the amount of $590,625.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a pilot study at the University of California, Los Angeles (UCLA) to investigate dual immunotherapy (PD1/CD73) in combination with chemotherapy for patients with pancreatic adenocarcinoma, with a focus on understanding the immune mechanisms of resistance. The award period runs from...
This federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award has a performance period from July 1, 2025 to June 30, 2028 and aims to transform healthcare for military service members, veterans, and the general public through innovative biomedical...